SCHEMBL1994348

SCHEMBL1994348

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(Cc2ccccc2OC)no1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.54
BCHE P06276 6/20 0.37
CHRM2 P08172 1/20 0.37
ACHE P22303 5/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CCR4 P51679 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
DRD2 P14416 1/20 0.35
DRD1 P21728 1/20 0.35
DRD3 P35462 1/20 0.35
SRC P12931 1/20 0.35
ZAP70 P43403 1/20 0.35
SCN1A P35498 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1989861 0.89 GHSR (0.50) GHSRCHRM2L3MBTL1ALDH1A1CCR4
SCHEMBL1991756 0.89 GHSR (0.62) GHSRL3MBTL1ALDH1A1CCR4MAPK1
SCHEMBL1990394 0.88 GHSR (0.49) GHSRCHRM2L3MBTL1ALDH1A1CCR4
SCHEMBL1991288 0.88 GHSR (0.49) GHSRCHRM2LMNAL3MBTL1ALDH1A1
SCHEMBL1990124 0.87 GHSR (0.56) GHSRBCHEACHELMNAL3MBTL1
SCHEMBL1990054 0.87 GHSR (0.54) GHSRCHRM2L3MBTL1ALDH1A1CCR4
SCHEMBL1988077 0.86 GHSR (0.55) GHSRCHRM2L3MBTL1ALDH1A1CCR4
SCHEMBL1994337 0.86 GHSR (0.57) GHSRBCHEACHELMNAL3MBTL1
SCHEMBL1991024 0.85 GHSR (0.49) GHSRCHRM2L3MBTL1CCR4DRD1
SCHEMBL1988473 0.84 GHSR (0.54) GHSRBCHELMNAL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885BCHE 1889/4885CHRM2 3419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.